In 2018, 36,528 transplants were performed in the U.S., as per the Health Resources and Services Administration. The figure seems high until we look at the number of people yet awaiting a transplant; as of July 2019, 113,000 people awaited their turn for a transplant in the U.S.
About 20 people lose their lives every day waiting for a transplant — lives that could be potentially saved by bridging the gap between the number of organs needed and those available. Artificial organs present the potential to save these lives, and the rising demand for organ transplants is the foremost factor providing impetus to the artificial organs market.
Accidents, health issues, and autoimmune diseases, among others, can lead to organ failure. Changing lifestyle and food patterns in the last two decades have also been exacerbating human health. While the need for organs is high, awareness associated with organ transplant remains low in many countries.
Table: Common Causes of Organ Failure
The technological marvel of 3D bioprinting has made artificial organ production possible. The technology is constantly evolving to enhance the effectiveness of artificial organs. Developments and breakthroughs in 3D bioprinting are, thus, expected to drive the artificial organs market during the forecast period.
Apart from the main organs, scientists have been successful in creating the thyroid gland with the help of technological advancements in 3D bioprinting. Further developments in the creation of complicated artificial organs are in the R&D phase. Production of the thyroid gland, a patch of actually beating heart cells, and tibia replacement are some of 3D bioprinting's latest phenomenal achievements.
Researchers at Stanford have stood by mathematics and microscopy for establishing the future of artificial organs as they seek to discover mathematical rules underpinning brain growth. They chose to examine the brain of a planarian, a millimeter-long flatworm capable of growing its head back after amputation. Results concluded that neuronal patterning in the human brain could one day be successfully and effectively used in the tissue engineering field, which is closely related to the development of artificial organs.
Out of the box researches are expected to be game-changers in the global artificial organs market. More focus and further research could one day lead to the functional and neuronal mapping of the brain, which may help in creating a highly effective artificial organ with numerous possibilities, including slow aging, frequent organ replacements, and many others.
The artificial organs market, for the purpose of our study, has been segmented on the basis of organ type.
The artificial kidneys segment accounted for a relatively high-value share in 2019. The prevalence of hepatitis B and C, diabetes, lupus, UTIs that tend to damage the kidneys, and long-term exposure to drugs such as NSAIDS contribute to the high incidence of kidney failure, which in turn accelerates the demand for artificial kidneys.
The artificial liver segment is expected to grow significantly in years to come with the rising consumption of alcohol among teenagers and geriatrics. The liver is prone to fattiness in case of heavy alcohol consumption for long durations. The last five years have seen a surge in the demand for artificial livers, which is largely attributable to changing lifestyles, predominantly among low to middle-income families.
The rising population of smokers has seen an upsurge in the number of respiratory failure cases. The rising prevalence of emphysema and chronic bronchitis on account of alarming pollution levels is translating to an increase in the need for artificial lung transplants in Bangladesh, Pakistan, India, Argentina, South Africa, and Dubai, among other countries.
The coronavirus pandemic and ever-increasing pollution levels are expected to see an increase in the demand for artificial lungs. The coronavirus pandemic is expected to particularly influence demand during 2021–2023 as the virus affects the respiratory system.
Fig: Estimated Share of Organ Type Segment, 2020–2029
North America dominates the artificial organs market. As per the U.S. Department of Health and Human Services' Health Resources and Services Administration, one person is added on the waiting list for organs every ten minutes. The number of people awaiting organs rose from 23,198 in 1991 to 115,000 in 2017, marking a five-fold increase. The number of children under 18 on the waiting list rose to 2,000 in 2019.
In light of the growing organ waiting list, governments are taking initiatives to support the R&D of artificial organs, which is expected to augment North America's artificial organs market. Rising awareness regarding the benefits of artificial organs, including no resistance from the body and short/no waiting time is expected to bolster the regional growth momentum in years to come.
Europe is the epicenter of the rapidly evolving 3D printing technology. Last year alone, the region saw a plethora of advancements in 3D bioprinting. The high prevalence of Crohn's disease, polycystic kidney disease, and diabetes, among other diseases, in Europe is translating into a higher rate of organ failure, particularly in Germany and the U.K.
Growth of medical tourism in drives South America's artificial organs market. Additionally, industrial growth is attracting investments from healthcare companies in the form of manufacturing plants in South America. High alcohol consumption and the increasing prevalence of several diseases are expected to further oversee an upsurge in the demand for artificial organs.
The Middle East and Africa region is expected to account for the smallest share in the global artificial organs market. Organ transplant patients in the Middle East prefer to travel to Asian countries for better and cheaper medical services. And in Africa, the poor economic scenario prevents accessibility to artificial organs.
|Market Size||USD in Billion By 2030|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
|Segments Covered||by Organ Type (Artificial Kidneys, Artificial Liver, Artificial Pancreas, Artificial Heart, and Artificial Lungs)|
|Geographies Covered||North America, Europe, Asia-Pacific, LAME and Rest of the World|
|Key Companies Profiled/Vendors||Braun Melsungen AG , Baxter International Inc, Boston Scientific Corporation , Getinge AB , Medtronic PLC ,|
|Key Market Opportunities||Growing Prevalence Of Healthcare It Industry Helps To Grow Artificial Organs Market Share|